G01N 2400/50
Lipopolysaccharides
Official title: Lipopolysaccharides; LPS
G01N2400/50 (Lipopolysaccharides) appears on 135 US grants and 177 published applications in this corpus.
Search patents in G01N- Granted patents
- 135
- Published applications
- 177
- Assignees
- 129
- Inventors
- 433
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 2 |
| 2002 | 5 | 1 |
| 2003 | 1 | 5 |
| 2004 | 2 | 4 |
| 2005 | 2 | 4 |
| 2006 | 0 | 4 |
| 2007 | 1 | 4 |
| 2008 | 2 | 7 |
| 2009 | 3 | 7 |
| 2010 | 3 | 7 |
| 2011 | 2 | 9 |
| 2012 | 3 | 4 |
| 2013 | 6 | 7 |
| 2014 | 7 | 6 |
| 2015 | 2 | 13 |
| 2016 | 3 | 10 |
| 2017 | 5 | 5 |
| 2018 | 9 | 9 |
| 2019 | 5 | 11 |
| 2020 | 4 | 8 |
| 2021 | 7 | 11 |
| 2022 | 4 | 14 |
| 2023 | 4 | 13 |
| 2024 | 8 | 4 |
| 2025 | 5 | 5 |
| 2026 | 5 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for producing an exdotoxin measuring agent29 Sep 2026US 12,748,115 B2Seikagaku Corporation
- Peptidoglycan (PGN) aptamers and associated methods19 May 2026US 12,631,636 B2Fresenius Medical Care Holdings, Inc.
- Lipopolysaccharide (LPS) aptamers and associated methods14 Apr 2026US 12,600,972 B2Fresenius Medical Care Holdings, Inc.
- Horseshoe crab factor B variant3 Feb 2026US 12,540,349 B2Seikagaku Corporation
- Recombinant amebocyte clotting factors and uses thereof3 Feb 2026US 12,540,944 B2Charles River Laboratories, Inc.
- Horseshoe crab factor b variant23 Jul 2026US 2026/0209822 A1Seikagaku Corporation
- Improved monocyte activation tests using human platelet serum2 Jul 2026US 2026/0185982 A1Mat Research B.V.
- Improved monocyte activation test19 Mar 2026US 2026/0079156 A1Mat Research B.V.
- Tetrasaccharides for the diagnosis, prevention, and treatment of melioidosis and glanders6 Nov 2025US 2025/0340580 A1Institut National De La Recherche Scientifique
- Reaction medium and associated method for detection of a target microorganism4 Sep 2025US 2025/0277250 A1
Most cited
By later US patents
- Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria112US 4,918,163 APfizer Inc. · 1990
- Methods for concentrating ligands using magnetic particles80US 6,348,318 B1Biosite Diagnostics, Inc. · 2002
- Generator for a windmill, stator module for use in such a generator and use of such a generator77US 6,781,276 B1Bonus Enegy A/S · 2004
- Colony blotting method and device49US 5,137,812 AMinnesota Mining and Manufacturing Company · 1992
- Invaplex from gram negative bacteria, method of purification and methods of use48US 6,245,892 B1The United States of America as represented by the Secretary of the Army · 2001